In vitro models show endometrial environment amplifies blastoid hCG production and bioactivity
This preclinical laboratory study investigated human chorionic gonadotropin (hCG) production and bioactivity using in vitro models designed to recapitulate aspects of human embryo peri- and early post-implantation stages. The models consisted of donor-derived endometrial epithelial cells forming an open-faced endometrial layer (OFEL) and human stem cell-derived blastoids. The study examined blastoid attachment to hormonally stimulated OFEL and compared co-cultures to OFEL alone or blastoids cultured alone.
Following blastoid attachment to hormonally stimulated OFEL, transcriptomic analysis identified CGA and CGB3/5/8 genes among the most strongly upregulated. Immunoassays and LHCGR activation assays confirmed the secretion of heterodimeric, biologically active hCG and its free subunits in co-culture conditioned media, but not in endometrial layers cultured alone. The predominant isoform detected was the hyperglycosylated hCG heterodimer. Co-culture with the endometrial component significantly increased hCG secretion compared with blastoids cultured alone, and this effect was further enhanced by hormonal priming in the peri-implantation model. Specific effect sizes, absolute numbers, and p-values were not reported.
Safety and tolerability data were not reported, as this was a laboratory model study. A key limitation is that the study uses in vitro models (OFEL and blastoids), not human embryos or in vivo conditions. The findings indicate an association within this specific model system; they describe a model recapitulating aspects of signaling but do not establish clinical causation for human pregnancy. Practice relevance is not established, as this is foundational research. The findings are from a preclinical in vitro model and should not be interpreted as applying directly to human pregnancy outcomes, implantation failure, or clinical management.